Disability, Cognition, and Quality of Life in Individuals With Multiple Sclerosis: A 2‐Year Cohort Study

Clinical and Experimental Neuroimmunology · Published 2026-04-29 · DOI 10.1111/cen3.70064

Authors being retrieved — see the publisher record. https://doi.org/10.1111/cen3.70064

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Not All Patients Start From the Same Line: Rethinking Outcome Interpretation in Myasthenia Gravis · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• Involvement of Regulatory T Cells in the Pathophysiology of Myasthenia Gravis: From a Pediatrician's Perspective · Clinical and Experimental Neuroimmunology · 2026 · Same journal
• Successful Treatment of Refractory Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease With Tocilizumab: A Case Report and Literature Review · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• Relapse and Neurological Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: A Retrospective Secondary Analysis of a Japanese Nationwide Epidemiologic Survey · Clinical and Experimental Neuroimmunology · 2026 · Same journal
• Autoimmune Cerebellar Ataxia Following TNF ‐α Inhibitor Therapy for Rheumatoid Arthritis: A Case Report · Clinical and Experimental Neuroimmunology · 2026 · Same journal
• Unveiling the Mysteries of Rare Neuroimmunological Disorders · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• Acute Denervation Revealed by Electromyography, in Conjunction With Normal Appearing Lumbar Spinal Cord in NMOSD : Case Report · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• Pulmonary Nodular Lymphoid Hyperplasia in a Case of Overlapping Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• Impact of Prior Intravenous Immunoglobulin and Plasmapheresis on Eculizumab or Ravulizumab Treatment for Generalized Myasthenia Gravis: An Analysis of the MG SPOTLIGHT Registry · Clinical and Experimental Neuroimmunology · 2025 · Same journal
• IgG4 ‐Related Disease Overlapping With Anti‐Acetylcholine Receptor Antibody–Positive Myasthenia Gravis · Clinical and Experimental Neuroimmunology · 2026 · Same journal